Berberine inhibits intestinal carcinogenesis by suppressing intestinal pro-inflammatory genes and oncogenic factors through modulating gut microbiota

Berberine inhibits intestinal carcinogenesis by suppressing intestinal pro-inflammatory genes and oncogenic factors through modulating gut microbiota

Abstract Background The role of Berberine (BBR) in colorectal cancer (CRC) and gut microbiota has begun to appreciate. However, there was no direct evidence confirm that the gut microbiota regulated by BBR could inhibit CRC. This report investigated the effect of stool from BBR treated subjects and...

Full description

Bibliographic Details
Main Authors: Haitao Chen, Chenxiao Ye, Biyu Cai, Fan Zhang, Xuanying Wang, Jin Zhang, Zewei Zhang, Yong Guo, Qinghua Yao
Format: Article
Language:English
Published: BMC 2022-05-01
Series:BMC Cancer
Subjects:
Berberine
Colorectal cancer
Gut microbiota
Fecal microbiota transplantation
Molecular mechanism
Cytokines
Online Access:https://doi.org/10.1186/s12885-022-09635-9

Internet

https://doi.org/10.1186/s12885-022-09635-9

Similar Items